We are live on
!
Find out more
UBS O'Connor Portfolio holdings
AUM
$3.76B
Turnover
54.76%
1-Year Est. Return
62.41%
This Fund
S&P 500
This Quarter
Est. Return
+13.06%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$4.23B
AUM Growth
+$208M
(+5.2%)
Cap. Flow
+$22.5M
Cap. Flow
% of AUM
0.53%
Top 10 Holdings %
Top 10 Hldgs %
66.8%
Holding
503
New
83
Increased
81
Reduced
97
Closed
181
Avg Time Held Equity + Options
1.1
years
Top 10 Avg Time Held Equity + Options
0.4
years
Top 20 Avg Time Held Equity + Options
0.4
years
Avg Time Held Equity only
1.1
years
Top 10 Avg Time Held Equity only
0.4
years
Top 20 Avg Time Held Equity only
0.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intra-Cellular Therapies Inc.
ITCI
|
+$383M |
| 2 |
Discover Financial Services
DFS
|
+$224M |
| 3 |
Beacon Roofing Supply, Inc.
BECN
|
+$183M |
| 4 |
Walgreens Boots Alliance
WBA
|
+$110M |
| 5 |
Nordstrom
JWN
|
+$95.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HashiCorp, Inc. Class A Common Stock
HCP
|
+$235M |
| 2 |
Smartsheet Inc.
SMAR
|
+$216M |
| 3 |
Endeavor Group Holdings, Inc.
EDR
|
+$144M |
| 4 |
Summit Materials, Inc. Class A Common Stock
SUM
|
+$103M |
| 5 |
Altair Engineering Inc
ALTR
|
+$97.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 17.21% |
| 2 | Healthcare | 16.93% |
| 3 | Financials | 12.93% |
| 4 | Industrials | 12.5% |
| 5 | Technology | 10.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
351
Crown Holdings
CCK
$12.4B
| – | – |
-213,370
| Closed | -$17.6M | – |
|
352
Coeur Mining
CDE
$15.8B
| – | – |
-800,000
| Closed | -$4.58M | – |
|
353
Cardlytics
CDLX
$12.1M
| – | – |
-45,000
| Closed | -$1.67M | – |
|
354
DELISTED
Confluent
CFLT
| – | – |
-262,500
| Closed | -$7.34M | – |
|
355
CG Oncology
CGON
$5.48B
| – | – |
-12,834
| Closed | -$368K | – |
|
356
Clean Harbors
CLH
$16.9B
| – | – |
-17,200
| Closed | -$3.96M | – |
|
357
CALL
Corcept Therapeutics
CORT
$12.3B
| – | – |
-40,000
| Closed | -$17.5K | – |
|
358
PUT
Coty
COTY
$2.81B
| – | – |
-1,264,500
| Closed | -$1.62M | – |
|
359
PUT
Capri Holdings
CPRI
$1.8B
| – | – |
-12,600
| Closed | -$494K | – |
|
360
DELISTED
CARGO Therapeutics
CRGX
| – | – |
-26,899
| Closed | -$388K | – |
|
361
CALL
CRISPR Therapeutics
CRSP
$4.98B
| – | – |
-20,000
| Closed | -$4K | – |
|
362
CALL
Community Health Systems
CYH
$422M
| – | – |
-270,000
| Closed | -$27K | – |
|
363
Deckers Outdoor
DECK
$11.8B
| – | – |
-10,000
| Closed | -$2.03M | – |
|
364
Dell
DELL
$301B
| – | – |
-4,000
| Closed | -$461K | – |
|
365
Denali Therapeutics
DNLI
$2.93B
| – | – |
-21,039
| Closed | -$429K | – |
|
366
Dow Inc
DOW
$21.4B
| – | – |
-261,700
| Closed | -$10.5M | – |
|
367
Precision BioSciences
DTIL
$170M
| – | – |
-15,534
| Closed | -$59.2K | – |
|
368
CALL
DexCom
DXCM
$33.1B
| – | – |
-20,000
| Closed | -$108K | – |
|
369
CALL
Dyne Therapeutics
DYN
$2.86B
| – | – |
-20,000
| Closed | -$49K | – |
|
370
e.l.f. Beauty
ELF
$6.85B
| – | – |
-7,500
| Closed | -$942K | – |
|
371
PUT
EPR Properties
EPR
$4.22B
| – | – |
-25,700
| Closed | -$1.93K | – |
|
372
Elastic
ESTC
$10.2B
| – | – |
-5,000
| Closed | -$495K | – |
|
373
CALL
Edgewise Therapeutics
EWTX
$4.15B
| – | – |
-15,000
| Closed | -$4.88K | – |
|
374
F5
FFIV
$25.9B
| – | – |
-6,000
| Closed | -$1.51M | – |
|
375
Fluor
FLR
$6.38B
| – | – |
-106,130
| Closed | -$5.23M | – |
|
Similar funds
RC
A
CGL
CB
JCM
MPM
UBS O'Connor's Q1 2025 Portfolio in Review
As of Q1 2025, UBS O'Connor held 503 positions worth $4.23B, up 5.2% from $4.02B the previous quarter. Its ten largest holdings account for 67% of the portfolio.
UBS O'Connor's Q1 2025 filing shows 83 new, 81 increased, 97 reduced and 181 closed positions. Its largest new stake was Beacon Roofing Supply, Inc.: 1,575,016 shares worth $195M. The largest sale was HashiCorp, Inc. Class A Common Stock, an estimated $235M.
By sector, the portfolio is most concentrated in Energy at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.
- UBS O'Connor's largest Q1 2025 buy was Beacon Roofing Supply, Inc.: 1,575,016 shares worth $195M.
- UBS O'Connor added most to Intra-Cellular Therapies Inc. in Q1 2025, an estimated $383M increase.
- UBS O'Connor's biggest Q1 2025 reduction was Juniper Networks, cutting an estimated $71.4M.
- UBS O'Connor fully exited HashiCorp, Inc. Class A Common Stock in Q1 2025, selling an estimated $235M.
- UBS O'Connor's ten largest holdings make up 67% of its $4.23B portfolio in Q1 2025.
- UBS O'Connor opened 83 new positions and closed 181 in Q1 2025.
- UBS O'Connor's portfolio value rose 5.2% quarter-over-quarter to $4.23B.
Based on UBS O'Connor's 13F filing for Q1 2025, filed 15 May 2025.